Empagliflozin for No-reflow Phenomenon in PCI for STEMI
Empagliflozin for No-reflow Phenomenon in PCI for STEMI
Active, not recruiting · NCT06342141 · Registry updated 2026-04-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Empagliflozin for No-reflow Phenomenon in PCI for STEMI | Infarction, Necrosis, No-Reflow Phenomenon, Pathologic Processes, Pathological Conditions, Signs and Symptoms, ST-elevation myocardial infarction, cardiovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorder | Active, not recruiting | Phase 2 | 2026-04-15 | NCT06342141 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Instituto Nacional de Cardiologia Ignacio Chavez | 5 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| National Institute of Cardiology | Mexico City | Mexico | 1 |